Nitric oxide and the liver

Liver

Volumn 21, Issue 3, 2001, Pages 161-174

  Farzaneh Far, Ramin ^a   Moore, Kevin ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cirrhosis; Hyperdynamic; Liver; Microcirculation; Nitric oxide

Indexed keywords

NITRIC OXIDE;

BLOOD VESSEL FUNCTION; COMPLICATION; DATA ANALYSIS; HUMAN; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER PARENCHYMA; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; REVIEW; SYNTHESIS; SYSTEMIC CIRCULATION; TISSUE INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; MICROCIRCULATION; NITRIC OXIDE; VASODILATION;

EID: 0034954951     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.021003161.x     Document Type: Review

References (158)

1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
2. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
3. Nitric oxide: Discovery and impact on clinical medicine
4. Physiological reactions of nitric oxide and hemoglobin: A radical rethink
5. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control
6. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient
7. Biochemical characterization of human S-nitrosohemoglobin. Effects on oxygen binding and transnitrosation
8. Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity
9. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation
10. Coagulation abnormalities in liver disease
11. Platelet function in cirrhosis and the role of humoral factors
12. Platelet basal cytosolic calcium: The influence of plasma factors in cirrhosis
13. Evidence for the inhibitory role of guanosine 3′, 5-pm-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
14. Nitric oxide in platelets
15. Modulation of platelet aggregation by an L-arginine-nitric oxide pathway
16. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
17. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides
18. Current status of platelet NO synthases
19. Biological activity of S-nitrosothiols: The role of nitric oxide
20. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor
21. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties
22. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia
23. Bacterial lipopolysaccharide antagonizes transforming growth factor beta 1-induced apoptosis in primary cultures of hepatocytes
24. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways
25. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8
26. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
27. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release
28. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver
29. Circulatory changes in chronic liver disease
30. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
31. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis
32. Role of vasopressin in abnormal water excretion in cirrhotic patients
33. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
34. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
35. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
36. Hyperdynamic circulation of cirrhotic rats: Role of substance P and its relationship to nitric oxide
37. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis
38. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat
39. Augmented endogenous nitric oxide production in partial portal vein-ligated rats
40. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: Evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis
41. Nitric oxide production in arterial vessels of cirrhotic rats
42. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats
43. Enhanced nitric oxide synthase activity in portal hypertensive rabbits
44. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats
45. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide
46. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats
47. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
48. Glomerular actions of nitric oxide
49. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans
50. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
51. Increased endothelium-dependent renal vasodilation in cirrhotic rats
52. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats
53. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats
54. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites
55. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: Role of hyperglucagonism
56. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension
57. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide
58. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
59. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats
60. Impaired pressor reactivity in cirrhosis: Evidence for a peripheral vascular defect
61. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats
62. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
63. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites
64. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: Role of nitric oxide and endothelium
65. Vasodilatory responses of isolated arteries of cirrhotic rats
66. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide?
67. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis
68. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis
69. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis
70. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats
71. Hemodynamic characterization of chronic bile duct-ligated rats: Effect of pentobarbital sodium
72. NO over-production by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats
73. Intracellular localization and activation of endothelial nitric oxide synthase
74. Disruption of the endothelial nitric oxide synthase gene: Effect on vascular response to injury
75. Atherosclerosis and the two faces of endothelial nitric oxide synthase
76. Inducible nitric oxide synthase in the liver: Regulation and function
77. Inducible nitric oxide synthase: A little bit of good in all of us
78. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats
79. Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats
80. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats
81. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia
82. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites
83. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats
84. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats
85. Enzymatic function of nitric oxide synthases
86. Tetrahydrobiopterin and endothelial nitric oxide synthase activity
87. Biosynthesis of nitric oxide: Dependence on pteridine metabolism
88. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase
89. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity
90. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells
91. Tetrahydrobiopterin biosynthesis, regeneration and functions
92. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
93. A rodent model of cirrhosis, ascites, and bacterial peritonitis
94. Hyperdynamic circulation of cirrhotic rats with ascites: Role of endotoxin, tumour necrosis factor-alpha and nitric oxide
95. The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine
96. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock
97. Nitric oxide: Physiology, pathophysiology, and pharmacology
98. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines
99. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta
100. Adventitia as a source of inducible nitric oxide synthase in the rat aorta
101. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat
102. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress
103. Signal transduction of eNOS activation
104. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension
105. Renal function and effective beta-blockage in cirrhosis with ascites. Relationship with baseline sympathoadrenergic tone
106. Plasma levels of substance P in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion
107. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension
108. Enhanced endothelium-dependent vasodilation in patients with cirrhosis
109. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis
110. Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins
111. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis
112. Endogenous nitric oxide in exhaled air from patients with liver cirrhosis
113. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis
114. Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis
115. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis
116. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis
117. Serum and urinary nitrate levels in liver cirrhosis: Endotoxemia, renal function and hyperdynamic circulation
118. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation
119. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis
120. Liver microvascular architecture: An insight into the pathophysiology of portal hypertension
121. NO-mediated vasodilation in the rat liver. Role of hepatocytes and liver endothelial cells
122. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
123. Role of nitric oxide in the regulation of the hepatic micro-circulation in vivo
124. Hepatic microvasculature: Dynamic structure and its regulation
125. Intravital and electron microscopic observation of Ito cells in rat hepatic microcirculation
126. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
127. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
128. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo
129. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility
130. Vasoactive effect of endothelin-1 on rat liver in vivo
131. Endothelin-1 induces direct constriction of hepatic sinusoids
132. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
133. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
134. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids
135. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension
136. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia
137. Nitric oxide decreases oxidant-mediated hepatocyte injury
138. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia
139. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase
140. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia
141. Nitric oxide production in experimental alcoholic liver disease in the rat: Role in protection from injury
142. Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium
143. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
144. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat
145. Protective role of nitric oxide in ischemia and reperfusion injury of the liver
146. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver
147. Role of endogenous nitric oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-reperfusion
148. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R
149. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver
150. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
151. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation
152. Nitric oxide and oxygen radicals: A question of balance
153. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury
154. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes
155. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride
156. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
157. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock
158. p21ras as a common signaling target of reactive free radicals and cellular redox stress